Eli Lilly takes an equity stake in smart ring maker Oura to back patients on its GLP-1 drugs; deal size undisclosed.
July 15, 2026 12:33 PM EDT
Eli Lilly invests in Oura to support patients on GLP-1 drugs
Eli Lilly on Wednesday made an equity investment in wearable ring startup Oura as the drugmaker looks for ways to support patients taking its GLP-1 …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Think we're worth reading - tell Google.
Oura partners with Eli Lilly's LillyDirect to give GLP-1 patients free smart rings to track health changes; no data-sharing deal…
Oura, the smart ring maker, filed confidentially for an initial public offering after it reached an $11 billion valuation last…
Alongside the debut of Oura smaller Ring 5, the wearables company unveiled its plans to help users integrate health records and…
Signos raised $20 million for its approach to using continuous glucose monitors to help people lose weight. And Oura unveiled…
Smart ring maker Oura files confidentially for US initial public offering - SiliconANGLE
The company was valued at $11bn last October.
